Mega Genomics Declares RMB0.15 Final Dividend for FY2025

Bulletin Express

Mar 31

Mega Genomics Limited announced on 31 March 2026 a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025.

The dividend, subject to shareholder approval at the annual general meeting on 26 June 2026, will be paid in Hong Kong dollars; the exchange rate, ex-dividend date, record date, book-closure period and payment date will be disclosed in a subsequent notice. Tricor Investor Services Limited will serve as the share registrar for the distribution.

The company stated that no withholding tax applies to the declared dividend, and it has no listed warrants or convertible securities outstanding.

As at the announcement date, the board comprises three executive directors (Dr. Yu Rong, Ms. Lin Lin, Ms. Jiang Jing), one non-executive director (Ms. Guo Meiling) and three independent non-executive directors (Dr. Zhang Ying, Mr. Jia Qingfeng, Dr. Xie Dan).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1186741799"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186741799\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186741799?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186741799","market":"us","top_or_hot":-1,"title":"Mega Genomics Declares RMB0.15 Final Dividend for FY2025","media":"Bulletin Express","content":"<p>Mega Genomics Limited announced on 31 March 2026 a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025.</p>\n<p>The dividend, subject to shareholder approval at the annual general meeting on 26 June 2026, will be paid in Hong Kong dollars; the exchange rate, ex-dividend date, record date, book-closure period and payment date will be disclosed in a subsequent notice. Tricor Investor Services Limited will serve as the share registrar for the distribution.</p>\n<p>The company stated that no withholding tax applies to the declared dividend, and it has no listed warrants or convertible securities outstanding.</p>\n<p>As at the announcement date, the board comprises three executive directors (Dr. Yu Rong, Ms. Lin Lin, Ms. Jiang Jing), one non-executive director (Ms. Guo Meiling) and three independent non-executive directors (Dr. Zhang Ying, Mr. Jia Qingfeng, Dr. Xie Dan).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mega Genomics Declares RMB0.15 Final Dividend for FY2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMega Genomics Declares RMB0.15 Final Dividend for FY2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-31 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mega Genomics Limited announced on 31 March 2026 a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025.</p>\n<p>The dividend, subject to shareholder approval at the annual general meeting on 26 June 2026, will be paid in Hong Kong dollars; the exchange rate, ex-dividend date, record date, book-closure period and payment date will be disclosed in a subsequent notice. Tricor Investor Services Limited will serve as the share registrar for the distribution.</p>\n<p>The company stated that no withholding tax applies to the declared dividend, and it has no listed warrants or convertible securities outstanding.</p>\n<p>As at the announcement date, the board comprises three executive directors (Dr. Yu Rong, Ms. Lin Lin, Ms. Jiang Jing), one non-executive director (Ms. Guo Meiling) and three independent non-executive directors (Dr. Zhang Ying, Mr. Jia Qingfeng, Dr. Xie Dan).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06667","symbol_name":"美因基因","start_time":0,"source_url":"","article_id":"1186741799","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186741799","pubTimestamp":1774965815,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Mega Genomics Limited announced on 31 March 2026 a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025. The dividend, subject to shareholder approval at the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06667":"美因基因"},"translate_title":"兆丰基因宣派2025财年末期股息人民币0.15元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06667":1},"content_text":"Mega Genomics Limited announced on 31 March 2026 a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025.\nThe dividend, subject to shareholder approval at the annual general meeting on 26 June 2026, will be paid in Hong Kong dollars; the exchange rate, ex-dividend date, record date, book-closure period and payment date will be disclosed in a subsequent notice. Tricor Investor Services Limited will serve as the share registrar for the distribution.\nThe company stated that no withholding tax applies to the declared dividend, and it has no listed warrants or convertible securities outstanding.\nAs at the announcement date, the board comprises three executive directors (Dr. Yu Rong, Ms. Lin Lin, Ms. Jiang Jing), one non-executive director (Ms. Guo Meiling) and three independent non-executive directors (Dr. Zhang Ying, Mr. Jia Qingfeng, Dr. Xie Dan).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}